Core Cap Advisors, LLC Bristol Myers Squibb CO Transaction History
Core Cap Advisors, LLC
- $2.18 Billion
- Q1 2025
A detailed history of Core Cap Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Core Cap Advisors, LLC holds 18,896 shares of BMY stock, worth $885,277. This represents 0.05% of its overall portfolio holdings.
Number of Shares
18,896
Previous 17,501
7.97%
Holding current value
$885,277
Previous $989,000
16.48%
% of portfolio
0.05%
Previous 0.05%
Shares
12 transactions
Others Institutions Holding BMY
# of Institutions
2,806Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$8.97 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.06 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.44 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.11 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.6B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...